Article
Treatment of infected hip arthroplasty with antibiotic-impregnated calcium hydroxyapatite.
Department of Orthopaedic Surgery, Mie University Graduate School of Medicine, Mie, Japan.
The Journal of Arthroplasty (impact factor:
2.38).
02/2008;
23(1):145-50.
DOI:10.1016/j.arth.2006.09.009
pp.145-50
Source: PubMed
-
Citations (0)
- Cited In (1)
-
Article: Amelioration of anemia in the ICGN mouse, a renal anemia model, with a subcutaneous bolus injection of erythropoietin adsorbed to hydroxyapatite matrix.
[show abstract] [hide abstract]
ABSTRACT: The recombinant human erythropoietin (rhEPO) is used for the treatment of patients with renal anemia. However, rhEPO should be administered subcutaneously or intravenously three times a week. The repetitive injections of rhEPO result in burdens to patients. To resolve this problem, we investigated the sustaining release methods using an rhEPO-hydroxyapatite (HAp) made by spray-drying technique as the drug delivery system. Two types of rhEPO-HAp formulations were prepared; zinc (Zn) formulation and Zn and poly-L-lactic acid (PLA) formulation. These formulations were examined in genetically anemic model, ICGN (ICR-derived glomerulonephritis) mice. According to in vivo release test of rhEPO from HAp in ICGN mice, elevated plasma concentration of rhEPO could be maintained for more than 7 days. These mice showed the amelioration of anemia for more than 3 weeks post-administration without causing any side effect. In conclusion, Zn or Zn/PLA formulation of HAp was considered to be one of the useful carriers of rhEPO for long-term improvement of anemia.Journal of Veterinary Medical Science 10/2009; 71(10):1365-71. · 0.85 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
2 men
5 women
6 patients
additional debridement 2 years
antibiotic-impregnated calcium hydroxyapatite
consecutive patients
excellent drug delivery system
hip arthroplasty
infected hip arthroplasty
latest follow-up
patients
remaining one patient
resection arthroplasty
second stage
thorough debridement